Literature DB >> 1969993

Postexposure prophylaxis for rabies with antiserum and intradermal vaccination.

S Chutivongse1, H Wilde, C Supich, G M Baer, D B Fishbein.   

Abstract

The Thai Red Cross intradermal postexposure rabies treatment schedule was prospectively assessed in 100 Thai patients severely bitten by proven rabid animals. It consists of 0.1 ml of purified Vero cell rabies vaccine containing more than 2.5 IU of rabies antigen per 0.5 ml of reconstituted vaccine given intradermally at two sites on days 0, 3, and 7, followed by one 0.1 ml injection on days 30 and 90. The commercial vaccine used had an antigen content of 3.17 IU per 0.5 ml ampoule. Purified equine or human rabies immuno-globulin was also given on day 0 to patients with severe exposures. As much of the immunoglobulin as possible was infiltrated around the wounds. All patients were followed for 1 year post exposure. There were no deaths; the efficacy of the regimen was 100%. Antibody titre determination in a randomly selected subgroup showed seroconversion in all 10 patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1969993     DOI: 10.1016/0140-6736(90)90488-q

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

1.  Evaluation of a new five-injection, two-site,intradermal schedule for purified chick embryo cell rabies vaccine: A randomized, open-label, active-controlled trial in healthy adult volunteers in India.

Authors:  M K Sudarshan; S N Madhusudana; B J Mahendra; D H Ashwath Narayana; M S Ananda Giri; O Popova; H B Vakil
Journal:  Curr Ther Res Clin Exp       Date:  2005-07

2.  Human immune response to rabies nucleocapsid and glycoprotein antigens.

Authors:  S Kasempimolporn; T Hemachudha; P Khawplod; S Manatsathit
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

3.  Rabies in a nine-year-old child: The myth of the bite.

Authors:  Olivier Despond; Marisa Tucci; Hélène Decaluwe; Marie-Claude Grégoire; Jeanne S Teitelbaum; Nathalie Turgeon
Journal:  Can J Infect Dis       Date:  2002-03

Review 4.  Intradermal vaccination for infants and children.

Authors:  Akihiko Saitoh; Yuta Aizawa
Journal:  Hum Vaccin Immunother       Date:  2016-05-02       Impact factor: 3.452

5.  Efficacy of high-dose intra-dermal hepatitis B virus vaccine in previous vaccination non-responders with chronic liver disease.

Authors:  S Dhillon; C Moore; S D Li; A Aziz; A Kakar; A Dosanjh; A Beesla; L Murphy; D H Van Thiel
Journal:  Dig Dis Sci       Date:  2011-12-09       Impact factor: 3.487

6.  A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods.

Authors:  Mary J Warrell; Anna Riddell; Ly-Mee Yu; Judith Phipps; Linda Diggle; Hervé Bourhy; Jonathan J Deeks; Anthony R Fooks; Laurent Audry; Sharon M Brookes; François-Xavier Meslin; Richard Moxon; Andrew J Pollard; David A Warrell
Journal:  PLoS Negl Trop Dis       Date:  2008-04-23

Review 7.  [New aspects of rabies control].

Authors:  H Bourhy; G D de Melo; A Tarantola
Journal:  Bull Acad Natl Med       Date:  2020-09-18       Impact factor: 0.144

Review 8.  The Route of Administration of Rabies Vaccines: Comparing the Data.

Authors:  Deborah J Briggs; Susan M Moore
Journal:  Viruses       Date:  2021-06-27       Impact factor: 5.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.